Latest period
$1.43B
YoY change
+70.8%
5Y CAGR
+31.2%
Peak year (2025)
$1.08B
Latest annual
$1.08B
Free Cash Flow history chart for DexCom (DXCM) from 2003 to 2025
Latest: $1.08B
Free Cash Flow growth chart for DexCom (DXCM) from 2003 to 2025
Latest: +70.8%
Free Cash Flow history table for DexCom (DXCM) from 2003 to 2025
| 2025 | $1.08B | +70.8% | +$446.50M | ||
| 2024 | $630.70M | +23.2% | +$118.80M | ||
| 2023 | $511.90M | +68.0% | +$207.20M | ||
| 2022 | $304.70M | +471.7% | +$251.40M | ||
| 2021 | $53.30M | -80.7% | −$223.30M | ||
| 2020 | $276.60M | +105.7% | +$142.10M | ||
| 2019 | $134.50M | +139.8% | +$78.40M | ||
| 2018 | $56.10M | +115.8% | +$30.10M | ||
| 2017 | $26.00M | +5100.0% | +$25.50M | ||
| 2016 | $500.00K | -96.8% | −$15.20M | ||
| 2015 | $15.70M | +112.2% | +$8.30M | ||
| 2014 | $7.40M | -234.5% | +$12.90M | ||
| 2013 | −$5.50M | -87.1% | +$37.10M | ||
| 2012 | −$42.60M | +11.7% | −$4.47M | ||
| 2011 | −$38.13M | -23.0% | +$11.40M | ||
| 2010 | −$49.54M | +16.9% | −$7.16M | ||
| 2009 | −$42.38M | +6.1% | −$2.44M | ||
| 2008 | −$39.94M | +9.0% | −$3.29M | ||
| 2007 | −$36.65M | -22.2% | +$10.44M | ||
| 2006 | −$47.09M | +72.9% | −$19.86M | ||
| 2005 | −$27.23M | +92.0% | −$13.04M | ||
| 2004 | −$14.19M | +43.7% | −$4.32M | ||
| 2003 | −$9.87M | — | — |
- 2025$1.08B+70.8%
- 2024$630.70M+23.2%
- 2023$511.90M+68.0%
- 2022$304.70M+471.7%
- 2021$53.30M-80.7%
- 2020$276.60M+105.7%
- 2019$134.50M+139.8%
- 2018$56.10M+115.8%
- 2017$26.00M+5100.0%
- 2016$500.00K-96.8%
- 2015$15.70M+112.2%
- 2014$7.40M-234.5%
- 2013−$5.50M-87.1%
- 2012−$42.60M+11.7%
- 2011−$38.13M-23.0%
- 2010−$49.54M+16.9%
- 2009−$42.38M+6.1%
- 2008−$39.94M+9.0%
- 2007−$36.65M-22.2%
- 2006−$47.09M+72.9%
- 2005−$27.23M+92.0%
- 2004−$14.19M+43.7%
- 2003−$9.87M—
Free Cash Flow values are taken from DexCom's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at DexCom (DXCM)
Free Cash Flow for DexCom (DXCM): headline value $1.43B · YoY +70.8%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, DexCom (DXCM) free cash flow totalled $1.08B – surged 70.8% year-over-year.
DexCom free cash flow has grown for 4 consecutive years, with a +31.2% compound annual growth rate over 2020–2025 (5 years).
The highest annual free cash flow of $1.08B was reported in 2025. The lowest in the available history was −$49.54M in 2010.
DexCom Free Cash Flow by Year
DexCom Free Cash Flow 2025: $1.08B
DexCom posted free cash flow of $1.08B in 2025, surged 70.8% from 2024. This figure represents the highest annual value in the available history.
DexCom Free Cash Flow 2024: $630.70M
In 2024, DexCom reported free cash flow of $630.70M, grew 23.2% from 2023.
DexCom Free Cash Flow 2023: $511.90M
DexCom free cash flow in 2023 was $511.90M, surged 68.0% from 2022.
DexCom Free Cash Flow 2022: $304.70M
2022's free cash flow for DexCom came in at $304.70M, surged 471.7% from 2021.
DexCom Free Cash Flow 2021: $53.30M
DexCom free cash flow in 2021 was $53.30M.
See more financial history for DexCom (DXCM).
Sector peers by Free Cash Flow
Healthcare peers of DexCom (DXCM), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation